5
3
3
Addressing Anti-Competitive Health Care Contract Clauses Act
5/20/2025, 2:46 PM
Summary of Bill HR 3020
The bill titled "To require the Government Accountability Office to evaluate the effects of anticompetitive contracting clauses in contracts between health insurers and health care providers and to determine actions taken by the Federal Trade Commission and the Department of Justice relating to the use of such clauses in such contracts and to assess their ability to effectively enforce the Federal antitrust laws with respect to such use" was introduced in the 119th Congress on April 24, 2025.
Read the Full Bill
Current Status of Bill HR 3020
Bill HR 3020 is currently in the status of Bill Introduced since April 24, 2025. Bill HR 3020 was introduced during Congress 119 and was introduced to the House on April 24, 2025. Bill HR 3020's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of April 24, 2025
Bipartisan Support of Bill HR 3020
Total Number of Sponsors
3Democrat Sponsors
0Republican Sponsors
3Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 3020
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 3020
To require the Government Accountability Office to evaluate the effects of anticompetitive contracting clauses in contracts between health insurers and health care providers and to determine actions taken by the Federal Trade Commission and the Department of Justice relating to the use of such clauses in such contracts and to assess their ability to effectively enforce the Federal antitrust laws with respect to such use.
To require the Government Accountability Office to evaluate the effects of anticompetitive contracting clauses in contracts between health insurers and health care providers and to determine actions taken by the Federal Trade Commission and the Department of Justice relating to the use of such clauses in such contracts and to assess their ability to effectively enforce the Federal antitrust laws with respect to such use.
Comments
Sponsors and Cosponsors of HR 3020
Latest Bills
ENDS Chinese Vapes Act of 2026
Bill HR 8687May 9, 2026
Rural Community Hospital Demonstration Program Reauthorization
Bill S 4460May 9, 2026
CHARLIE Act
Bill HR 8705May 9, 2026
Disaster Declaration Transparency Act of 2026
Bill S 4433May 9, 2026
Protect the Presidency Act
Bill HR 8685May 9, 2026
NOPE Act of 2026
Bill S 4421May 9, 2026
No Funds for Iran War Act
Bill HR 8707May 9, 2026
Optimizing the VA Workforce for Veterans Act of 2026
Bill S 4400May 9, 2026
Strategic Export Controls and Border Security Enhancement Act
Bill HR 8689May 9, 2026
No Aid for Ghost Students Act of 2026
Bill S 4428May 9, 2026
